The DOI matches its OpenAlex record; 12 of the 12 references it cites were found in a registry or an index.
Diagnosis and Management of Neurological Sarcoidosis
Abstract
BACKGROUND: Neurological involvement is a significant cause of morbidity and mortality in patients with sarcoidosis. Detection and management of neurosarcoidosis remains problematic. Our interest in immunosuppressive agents for chronic sarcoidosis has given us experience with various agents for the treatment of sarcoidosis, including cyclophosphamide and methotrexate. METHODS: We analyzed all patients with sarcoidosis seen in our clinic during a 10-year period. Evaluation for neurological disease included routine physical examination. Magnetic resonance imaging, cerebral spinal fluid analysis, and neural tissue biopsy were performed where clinically indicated. Patients were treated with corticosteroids, methotrexate, or cyclophosphamide. RESULTS: Neurological disease was identified in 71 of 554 patients with sarcoidosis. Seventh (facial) cranial nerve paralysis was the most common manifestation identified in 39 patients. This included 24 patients with facial nerve palsy as the only manifestation of neurological sarcoidosis in whom complete recovery was seen in all but 1 patient. Forty-eight patients with disease other than facial nerve palsy received corticosteroids or other therapies. Corticosteroids benefited only 14 patients (29%). Methotrexate successfully treated 17 (61%) of 28 patients and cyclophosphamide controlled disease in 9 (90%) of 10 assessable patients. Methotrexate and cyclophosphamide were each associated with a higher response rate than corticosteroids alone (chi 2, 14.6; P < .001). CONCLUSIONS: Neurological symptoms can be significant manifestations of sarcoidosis. Facial nerve paralysis is a common, but usually self-limited form of disease. Other manifestations are usually chronic and agents other than corticosteroids appear to have increased efficacy with lower morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mayock, R. L., Bertrand, P., Morrison, C. E., & Scott, J. H. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90165-7 · Cited by 800
Sarcoidosis and Its Neurological Manifestations
Stern, B. J., Krumholz, A., Johns, C., Scott, P., & Nissim, J. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060080095022 · Cited by 714
Neurologic Manifestations in Sarcoidosis: Review of the Literature, with a Report of 23 Cases
DELANEY, P. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-3-336 · Cited by 560
Course and prognosis of sarcoidosis around the world
Siltzbach, L. E., James, D. G., Neville, E., Turiaf, J., Battesti, J. P., Sharma, O. P., Hosoda, Y., Mikami, R., & Odaka, M. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90160-0 · Cited by 526
Cyclophosphamide-induced hemorrhagic cystitis: A review of 100 patients
Stillwell, T. J., & Benson, R. C. (1988) · Cancer · doi:10.1002/1097-0142(19880201)61:3<451::aid-cncr2820610308>3.0.co;2-g · Cited by 304
Lexa, F. J., & Grossman, R. I. (1994) · PubMed Central · Cited by 168
Use of Intermittent, Intravenous Cyclophosphamide for Idiopathic Pulmonary Fibrosis
Baughman, R. P., & Lower, E. E. (1992) · CHEST Journal · doi:10.1378/chest.102.4.1090 · Cited by 96
Self-citationMyocardial Sarcoidosis Unresponsive to Steroids
Demeter, S. L. (1988) · CHEST Journal · doi:10.1378/chest.94.1.202 · Cited by 84
Clinical Implications of Seizures in Neurosarcoidosis
Krumholz, A., Stern, B. J., & Stern, E. G. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200084023 · Cited by 76
Neurosarcoidosis Associated with Hypersomnolence Treated with Corticosteroids and Brain Irradiation
Rubinstein, I., Gray, T. A., Moldofsky, H., & Hoffstein, V. (1988) · CHEST Journal · doi:10.1378/chest.94.1.205 · Cited by 57
Cited by
ERS clinical practice guidelines on treatment of sarcoidosis
Baughman, R. P., Valeyre, D., Korsten, P., Mathioudakis, A. G., Wuyts, W. A., Wells, A., Rottoli, P., Nunes, H., Lower, E. E., Judson, M. A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04079-2020 · Cited by 629
Self-citationNeurosarcoidosis: a clinical dilemma
Hoitsma, E., Faber, C. G., Drent, M., & Sharma, O. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00805-1 · Cited by 382
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Judson, M. A., Baughman, R. P., Costabel, U., Flavin, S., Lo, K. H., Kavuru, M. S., Drent, M., & the Centocor T48 Sarcoidosis investigators (2008) · European Respiratory Journal · doi:10.1183/09031936.00051907 · Cited by 324
The Clinical Features of Sarcoidosis: A Comprehensive Review
Judson, M. A. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8450-y · Cited by 281
Ribeiro Neto, M. L., Jellis, C. L., Joyce, E., Callahan, T. D., Hachamovitch, R., & Culver, D. A. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-119cme · Cited by 63
Metadata
- Authors
- Lower, E. E.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1997-09-08
- Volume
- 157
- Issue
- 16
- Pages
- 1864-1864
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1992474954
- Cited by
- 330
- References
- 12
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and Management of Neurological Sarcoidosis. https://app.cochat.ai/papers/10.1001/archinte.157.16.1864
- The paper
- Lower, E. E. (1997). Diagnosis and Management of Neurological Sarcoidosis. Archives of Internal Medicine. https://doi.org/10.1001/archinte.157.16.1864
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.